Haemonetics Corp. (hae 0 03/01/26)
13F holders, Q2 2025 (June 30)9holders +1
2new positions
1sold out
$0.96avg. 13F price*
At the end of Q2 2025, 9 institutions reported holding Haemonetics Corp. (hae 0 03/01/26) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 1 sold out. The largest holders were Angelo Gordon & Co., L.P. ($5.8M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.9M) and Sei Investments Co. ($323K).
- Company
- Haemonetics Corp. (hae 0 03/01/26)
- CUSIP
- 405024AB6
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $23K |
| Exits | 1 | $40K |
All 13F filers, Q1 2025 → Q2 2025: 26,000 shares bought and 1,044,000 shares sold, net −1,018,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Angelo Gordon & Co., L.P. | 0.93% | No change | 6,000,000 | $5.8M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Reduce -25.0% | 3,000,000 | $2.9M |
| Sei Investments Co. | 0.00% | No change | 335,000 | $323K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -0.5% | 189,000 | $182K |
| Stephens Inc. | 0.00% | Add +3.5% | 59,000 | $57K |
| LPL Financial LLC | 0.00% | Reduce -2.4% | 40,000 | $39K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 20,000 | $19K |
| HB Wealth Management, LLC | 0.00% | New | 13,000 | $13K |
| &partners | 0.00% | New | 11,000 | $11K |
"% of holder's portfolio" is HAEMONETICS CORP (HAE 0 03/01/26)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 0 03/01/26) the manager owns.